Syngenix Limited

SynGenix Limited SynGenix has developed technologies that effectively target drugs and drug discovery tools to the anatomical and cellular sites of origin of disease processes. SynGenix can delivery probes such as antisense in vivo for > drug target validation and systems for targeting small drugs and macromolecules to the site of disease. The core platform technologies have been demonstrated by the intracellular delivery of drugs to treat chronic pain and the delivery of antisense to block HIV. SynGenix now intends to take technology to treat chronic and acute pain into man over the coming 24 months and to develop related technologies to target therapeutic and probe molecules to address other unmet disease needs.

Contact Details: Babraham Hall Babraham Cambridge Cambridgeshire CB2 4AT United Kingdom Tel: +44 1223 496090 Fax: +44 1223 496018 Email: WWW: www.syngenix.com/

Loading...

Syngenix Limited Patents:
US Patent No.	Title
6919067	Compositions comprising a tissue glue and therapeutic agents
6562318	Particular agents
6294165	Defective packaging non-oncoviral vectors based on HIV
6153598	Synthetic transfection vectors
5948384	Particulate agents
→View more Syngenix Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 821 times since April 2007, the link to the organisation's website has been followed 211 times

Recent Search Terms used to find this page: Syngenix | syngenix | syngenix 6294165 | syngenix ltd | Syngenix | Syngenix | syngenix | syngenix | .

Search for more companies in Cambridge

Search for more companies in Cambridgeshire

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Syngenix Limited